-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Downgrades OptiNose to Neutral, Lowers Price Target to $9

Benzinga·03/21/2025 15:26:08
Listen to the news
Piper Sandler analyst David Amsellem downgrades OptiNose (NASDAQ:OPTN) from Overweight to Neutral and lowers the price target from $15 to $9.